Covaxin neutralises double mutant strain of Covid-19: ICMR | Editorji
  1. home
  2. > national
  3. > Covaxin neutralises Covid double mutant strain: ICMR
prev iconnext button of playermute button of playermaximize icon
mute icontap to unmute
video play icon
00:00/00:00
prev iconplay paus iconnext iconmute iconmaximize icon
close_white icon

Covaxin neutralises Covid double mutant strain: ICMR

Apr 21, 2021 15:29 IST | By Editorji News Desk

Indian Covid vaccine, Covaxin, has been found to effectively neutralise the double mutant strain and other variants of Covid-19, Indian Council of Medical Research (ICMR) has said. Covaxin is made by Bharat Biotech. The top medical body said that it is a good news which will reduce anxiety among people in the second wave. ICMR scientists have said that their research has demonstrated the neutralization potential of Covaxin against the UK variant and Brazil variant. The data for the South African variant is being generated. Double mutant strain B.1.617 is currently prevalent in certain regions of India. Meanwhile, Bharat Biotech has said Covaxin has shown 78 pc efficacy against mild to severe COVID-19.

National